Mr Mrs Miss Ms Dr Other

Ms
Sarah
De'Ath

Senior Trade Mark Attorney

London Office

Trade marks

Telephone. +44(0) 207 776 5100
Email. sdeath@hgf.com

Experience

Sarah is involved in all aspects of trade mark law, and advises clients on clearance searches, trade mark prosecution and contentious matters. She works with clients across a wide range of business sectors.

Sarah has particular experience working with clients in the healthcare industry, having started her trade mark career working in-house for a worldwide pharmaceutical company. At HGF, Sarah has handled trade mark and domain name disputes for clients in the human and veterinary pharmaceutical sectors. She has also been involved in carrying out various trade mark audits over the years, including a large-scale audit for a multinational pharmaceutical company.

Sarah also works with clients in the fields of financial services, fashion and the automotive sector among others.

She also has significant experience in handling certification and collective mark applications.

Directly prior to joining HGF, Sarah worked at a multinational energy company for a number of years where she provided support to the in-house trade mark team.

Specialisms

Industries

Services

Qualifications

Trade Mark Attorney

Chartered (UK)


BA

English

MA

Viking & Anglo-Saxon Studies

POSTGRADUATE DIPLOMA OR CERTIFICATE

Postgraduate Certificate in Intellectual Property

POSTGRADUATE DIPLOMA OR CERTIFICATE

Professional Certificate in Trade Mark Practice

Related News

Office Closed Dates December 2025 / January 2026

HGF Office Closed Dates December 2025 / January 2026   UK Thursday 25 and Friday 26 December 2025 CLOSED Thursday 1 January 2026* CLOSED * Friday 2 January 2026 – …

Read article

PRESS RELEASE – HGF strengthens European presence with three new Partners in France and Germany

HGF is pleased to announce the arrival of three new partners, further strengthening its European presence. Two partners will be joining the firm’s fast-growing French practice, and one will join …

Read article

G1/23: The Enlarged Board of Appeal shift EPO practice towards an “on-sale” bar.

Last week, the EPO’s Enlarged Board of Appeal (EBA) issued its Decision that both a product put on the market before the date of filing of a European patent application, …

Read article

The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

Read article

The concept of ‘overall impression’ in UK and EU Registered Design Law

 

Read article

The Antibody Series #2 | Definition via binding strength in antibody claims: when “binds strongly... but only minimally...” becomes a trap of lack of clarity

Introduction Defining an antibody by its binding strength is common practice in patent claims, but it can quickly become a pitfall under Article 84 EPC on clarity. In this second …

Read article

The Antibody Series #1 | Quality Characteristics (CQAs) in Antibody Claims: When the Test Method Can Remain Outside the Claim

Introduction Therapeutic antibodies are at the heart of innovations in biotechnology and healthcare. With increasing regulatory requirements and quality expectations, critical quality attributes (CQAs) are becoming essential in the drafting …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.